Whittier Trust CO Vertex Pharmaceuticals Inc Transaction History

Whittier Trust CO

$7.37 Billion
Q3 2024

A detailed history of Whittier Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Whittier Trust CO holds 1,533 shares of VRTX stock, worth $691,337. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,533

Previous 1,447 5.94%

Holding current value

$691,337

Previous $678,000 5.01%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$460.0 - $505.78 $39,560 - $43,497	86 Added 5.94%	1,533 $712,000
Q2 2024 Jul 26, 2024	BUY	$392.81 - $485.53 $47,922 - $59,234	122 Added 9.21%	1,447 $678,000
Q1 2024 May 02, 2024	BUY	$407.69 - $446.08 $26,499 - $28,995	65 Added 5.16%	1,325 $553,000
Q4 2023 Jan 11, 2024	BUY	$343.0 - $410.68 $125,195 - $149,898	365 Added 40.78%	1,260 $512,000
Q3 2023 Oct 27, 2023	SELL	$338.18 - $362.46 $15,556 - $16,673	-46 Reduced 4.89%	895 $311,000
Q2 2023 Jul 24, 2023	SELL	$314.42 - $351.91 $3,458 - $3,871	-11 Reduced 1.16%	941 $331,000
Q4 2022 Jan 25, 2023	SELL	$285.76 - $321.48 $47,721 - $53,687	-167 Reduced 14.92%	952 $0
Q3 2022 Oct 21, 2022	SELL	$273.83 - $305.53 $5,476 - $6,110	-20 Reduced 1.76%	1,119 $324,000
Q2 2022 Jul 28, 2022	SELL	$234.96 - $292.55 $3,289 - $4,095	-14 Reduced 1.21%	1,139 $321,000
Q1 2022 Apr 29, 2022	BUY	$221.42 - $260.97 $1,992 - $2,348	9 Added 0.79%	1,153 $301,000
Q4 2021 Jan 19, 2022	BUY	$177.01 - $223.45 $39,650 - $50,052	224 Added 24.35%	1,144 $251,000
Q3 2021 Nov 01, 2021	SELL	$181.39 - $202.99 $7,255 - $8,119	-40 Reduced 4.17%	920 $167,000
Q2 2021 Jul 29, 2021	SELL	$187.49 - $221.1 $13,124 - $15,477	-70 Reduced 6.8%	960 $194,000
Q1 2021 Apr 26, 2021	BUY	$207.02 - $241.31 $1,035 - $1,206	5 Added 0.49%	1,030 $221,000
Q4 2020 Jan 29, 2021	SELL	$207.01 - $276.09 $23,599 - $31,474	-114 Reduced 10.01%	1,025 $242,000
Q3 2020 Oct 30, 2020	BUY	$255.65 - $303.1 $5,624 - $6,668	22 Added 1.97%	1,139 $310,000
Q2 2020 Jul 10, 2020	BUY	$225.48 - $295.8 $31,341 - $41,116	139 Added 14.21%	1,117 $324,000
Q1 2020 Apr 27, 2020	BUY	$199.77 - $247.81 $2,597 - $3,221	13 Added 1.35%	978 $232,000
Q4 2019 Jan 31, 2020	SELL	$166.71 - $223.91 $2,167 - $2,910	-13 Reduced 1.33%	965 $211,000
Q3 2019 Oct 18, 2019	BUY	$166.23 - $187.09 $20,612 - $23,199	124 Added 14.52%	978 $166,000
Q2 2018 Jul 27, 2018	BUY	$145.72 - $169.96 $63,242 - $73,762	434 Added 103.33%	854 $145,000
Q2 2018 Jul 20, 2018	SELL	$145.72 - $169.96 $83,206 - $97,047	-571 Reduced 57.62%	420 $40,000
Q4 2017 Feb 07, 2018	BUY	$137.28 - $155.55 $82,368 - $93,330	600 Added 153.45%	991 $149,000
Q3 2017 Oct 23, 2017	BUY	$148.13 - $162.24 $57,918 - $63,435	391	391 $59,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.

Account

Whittier Trust CO Vertex Pharmaceuticals Inc Transaction History